Steve Caffé was most recently Vice President, Global Regulatory Affairs and Pharmacovigilance at Baxter International where he has led the global transformation of the function since January 2006 across business units and regions. Steve has 20 years of experience in the pharmaceutical industry in medical affairs, clinical and regulatory development, and product safety across all major therapeutic areas and including drugs, biologics, vaccines, and medical devices. Before joining Baxter, Steve was Vice President of Global Regulatory Development at Aventis and sanofi-aventis in Bridgewater, NJ from 2001 to 2006. He also previously held positions of increasing responsibilities in both international and domestic Regulatory Affairs at Merck & Co. in West Point, PA from 1992 to 2001. Prior, he was responsible for Medical Affairs for cardiovascular drugs at Parke-Davis in France. Steve received his medical degree from the Faculté de Médecine Saint-Antoine, Université Pierre et Marie Curie (Paris VI). He completed his internship and residency at Assistance Publique - Hôpitaux de Paris and prior to joining industry, practiced medicine at the academic hospitals of Paris with a focus on emergency and intensive care. Steve’s accomplishments in industry include the global registration of several new chemical entities, successfully managing complex business and regulatory issues, and assembling and leading high-performing teams.